The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations

Author(s):
Hartog, A.W. den; Franken, R.; Berg, M.P. van den; Zwinderman, A.H.; Timmermans, J.; Scholte, A.J.; Waard, V. de; Spijkerboer, A.M.; Pals, G.; Mulder, B.J.M.; Groenink, M.
Published
2016
Publication type
Article / Letter to editor
Marfan syndromeVentricular functionVentricular volumesLosartanCardiac magnetic resonance imagingFBN1 mutation classes
Date issued
2016-11-30
Language
English
Is part of
Netherlands Heart Journal (2016), Vol. 24, no. 11, p. 675-681
hdl
1887/114188
doi
10.1007/s12471-016-0905-8